全球麻疹疫苗市場規模（按疫苗類型、最終用戶、通路、區域覆蓋範圍和預測）：

麻疹疫苗市場規模及預測

近年來，麻疹疫苗市場規模以中等速度成長，成長率相當高，預計在市場估計和預測期內（2026-2032年）將大幅成長。

推動全球麻疹疫苗市場的因素

麻疹疫苗市場的促進因素可能受到多種因素的影響。這些因素包括：

• 全球免疫工作：各國政府和國際組織為提高疫苗接種率所做的努力可能會影響麻疹疫苗接種的需求，尤其是在較貧窮的國家。
• 提高意識：透過進行公共宣導活動強調接種疫苗對於避免麻疹爆發的價值，可以增加疫苗需求。
• 政府規定：強制在學校等公共場所接種麻疹疫苗可以增加疫苗的需求。
• 疫情與疫情：隨著社區和政府努力控制麻疹的傳播，世界各地可能會發生麻疹疫情，增加免疫接種的需求。
• 人口成長：隨著世界人口的成長，接種疫苗以保護更多人免受麻疹等傳染病的侵害的需求也在成長。
• 技術發展：例如，新疫苗配方和輸送系統的開發可以提高疫苗對患者和醫療保健專業人員的可用性和吸引力。
• 研發投入：開發更有效、更實惠的麻疹疫苗以及持續的研究和發展可以促進市場發展。
• 政府資金支持：各國政府和國際免疫計畫組織對麻疹疫苗的採購和分發提供資金支持，這將成為市場擴張的動力。
• 增加醫療保健支出：醫療保健成本的發展，尤其是在開發中國家，可能會增加疫苗宣傳活動的資金並增加對麻疹疫苗的需求。
• 全球化和旅行：由於移民和國際旅行的增加，麻疹等感染疾病可能更容易傳播，這增加了接種疫苗的必要性，以保護社區和旅行者免受輸入病例的侵害。

限制全球麻疹疫苗市場的因素

麻疹疫苗市場可能面臨多種限制或挑戰，包括：

• 父母和看護者不願意為孩子接種疫苗，是因為擔心疫苗的安全性和有效性，這可能會影響疫苗接種率，最終影響市場需求。
• 醫療保健機會有限：在醫療保健設施不足或疫苗接種機會有限的地區，分發方法可能不足，麻疹疫苗可能無法涵蓋弱勢群體。
• 供應鏈挑戰：供應鏈的複雜性和物流問題可能會影響麻疹疫苗的分發和可近性，尤其是在農村和人口稀少的地區。
• 價格敏感性：疫苗成本可能超出家庭和醫療保健預算，尤其是在低收入地區。
• 監管障礙：嚴格的監管，包括冗長的核准流程和合規要求，可能會阻止製造商進入某些市場或延遲新疫苗的推出。
• 優先事項相互競爭：在存在衛生優先事項相互競爭或疾病對公共衛生具有更大重要性的地區，資源和重點可能會從麻疹疫苗接種計劃轉移。
• 應對疫情的挑戰：疫情會暫時增加對麻疹疫苗接種的需求，但有效對抗疫情需要迅速調動資源和協調公共衛生措施，可能會帶來後勤挑戰。
• 低溫運輸需求：麻疹疫苗通常需要在低溫運輸中儲存和運輸，這在資源有限或基礎設施不穩定的環境中可能難以維持。
• 疫苗開發成本：如果疫苗的潛在市場較小，開發新疫苗或改善現有疫苗的研發成本可能會阻礙投資。
• 全球經濟因素：政府對醫療保健和免疫計畫的資助可能會受到景氣衰退或國際市場波動的影響，進而影響對麻疹疫苗的需求。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

4. 麻疹疫苗市場（依疫苗類型）

• 減毒麻疹疫苗
• 麻疹-腮腺炎-德國德國麻疹(MMR) 疫苗
• 麻疹-德國麻疹（MR）疫苗
• 成人麻疹疫苗

5. 麻疹疫苗市場（依最終用戶）

• 孩子們
• 成人
• 高危險群

6. 麻疹疫苗市場（依通路）

• 醫院和診所
• 零售藥局
• 政府疫苗接種計劃

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• Sanofi
• Serum Institute of India Pvt. Ltd.
• Astellas Pharma India Private Limited
• Emergent BioSolutions Inc.
• GlaxoSmithKline plc

第11章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Measles Vaccine Market Size And Forecast

Measles Vaccine Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2026 to 2032.

Global Measles Vaccine Market Drivers

The market drivers for the Measles Vaccine Market can be influenced by various factors. These may include:

• Global Immunisation Initiatives: The demand for measles vaccinations may be influenced by initiatives taken by governments and international organisations to raise vaccination rates, particularly in poor nations.
• Increasing Awareness: Vaccine demand may be fueled by public awareness efforts emphasising the value of immunisation in averting measles outbreaks.
• Government Regulations: Enforcing immunisation against measles in public settings, such as schools, can increase demand for the vaccine.
• Epidemics and Outbreaks: As communities and governments work to stop the disease's spread, measles outbreaks in different regions of the world may result in a rise in the demand for vaccinations.
• Population Growth: In order to protect more individuals from contagious diseases like the measles, vaccinations are becoming more and more necessary as the world's population rises.
• Technological developments: The creation of novel vaccine formulations or delivery systems, for example, can improve vaccine accessibility and appeal to patients and healthcare professionals.
• Investment in Research and Development: The development of more potent and reasonably priced measles vaccinations, as well as ongoing research and development initiatives, could propel market expansion.
• Government Funding: Purchasing and distributing measles vaccinations can be aided by funding from governments and international organisations for immunisation programmes, which will propel market expansion.
• Growing Healthcare Expenditure: Growing healthcare costs, especially in developing nations, may result in more funding for immunisation campaigns, which will raise demand for measles vaccines.
• Globalisation and Travel: As a result of increased migration and international travel, infectious diseases such as the measles can spread more easily, increasing the need for vaccinations to protect communities and travellers against imported cases.

Global Measles Vaccine Market Restraints

Several factors can act as restraints or challenges for the Measles Vaccine Market. These may include:

• Parental and carer reluctance: to vaccinate their children can be attributed to worries about the safety and effectiveness of vaccines. This can have an impact on vaccination rates and, in turn, market demand.
• Limited Access to Healthcare: Distribution methods may not be sufficient in areas with weak healthcare facilities or limited access to vaccines, which would prevent the measles vaccine from reaching vulnerable populations.
• Difficulties with the Supply Chain: Especially in rural or underdeveloped areas, supply chain complexity and logistical problems might impact the distribution and accessibility of measles vaccinations.
• Price Sensitivity: In certain markets, affordability can be a major obstacle, especially in low-income areas where the cost of vaccines may be more than what individual households or healthcare budgets can afford.
• Regulatory Barriers: Tight regulations, such as protracted licencing procedures and compliance requirements, might prevent manufacturers from entering certain markets or postpone the release of new vaccines.
• Competing Priorities: Resources and focus may be shifted away from measles vaccination programmes in areas where there are competing health priorities or diseases that are of higher public health significance.
• Challenges Associated with Outbreak Response: Although outbreaks can momentarily increase demand for measles vaccinations, effectively combating outbreaks necessitates the quick deployment of resources and coordinated public health initiatives, which could provide logistical difficulties.
• Cold Chain Requirements: Measles vaccinations usually need to be stored and transported in a cold chain, which can be difficult to maintain in environments with limited resources or unstable infrastructure.
• Vaccine Development Costs: If the potential market for a vaccine is small, the research and development expenses involved in creating new vaccines or refining current ones may discourage investment.
• Global Economic Factors: Government funding on healthcare and immunisation programmes can be impacted by economic downturns or variations in international markets, which may have an impact on the demand for measles vaccines.

Global Measles Vaccine Market Segmentation Analysis

The Global Measles Vaccine Market is Segmented on the basis of Vaccine Type, End-User, Distribution Channel, and Geography.Measles

Measles Vaccine Market, By Vaccine Type

• Live Attenuated Measles Vaccine: This type of vaccine contains a weakened form of the measles virus, which stimulates an immune response without causing the disease.
• Measles-Mumps-Rubella (MMR) Vaccine: This vaccine combines protection against measles with mumps and rubella. It's commonly administered in childhood immunization schedules.
• Measles-Rubella (MR) Vaccine: Similar to MMR, but excludes mumps. It's used in regions where rubella remains a concern.
• Measles Vaccine for Adults: Vaccines specifically formulated for adult populations, often for those who missed childhood vaccinations or need boosters.

Measles Vaccine Market, By Distribution Channel

• Hospitals & Clinics: Vaccines distributed through healthcare facilities, including hospitals, clinics, and medical centers.
• Retail Pharmacies: Distribution through pharmacies where individuals can directly purchase vaccines or obtain them with a prescription.
• Government Immunization Programs: Vaccines distributed as part of national or regional immunization campaigns organized by government health departments.

Measles Vaccine Market, By End-User

• Pediatric Population: Vaccines administered to infants and children as part of routine childhood immunization schedules.
• Adult Population: Vaccines administered to adolescents and adults, including travelers and healthcare workers who may be at higher risk of exposure.
• High-Risk Groups: Vaccines targeted at specific high-risk groups such as pregnant women, healthcare workers, or immunocompromised individuals.

Measles Vaccine Market, By Geography

• North America: Market conditions and demand in the United States, Canada, and Mexico.
• Europe: Analysis of the Measles Vaccine Market in European countries.
• Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa: Examining market dynamics in the Middle East and African regions.
• Latin America: Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Measles Vaccine Market are
• Johnson & Johnson
• MedImmune
• Merck & Co. Inc.
• Bavarian Nordic
• CSL Limited
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Astellas Pharma India Private Limited
• Emergent BioSolutions Inc.
• GlaxoSmithKline plc

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Measles Vaccine Market, By Vaccine Type

• Live Attenuated Measles Vaccine
• Measles-Mumps-Rubella (MMR) Vaccine
• Measles-Rubella (MR) Vaccine
• Measles Vaccine for Adults

5. Measles Vaccine Market, By End-User

• Pediatric Population
• Adult Population
• High-Risk Groups

6. Measles Vaccine Market, By Distribution Channel

• Hospitals & Clinics
• Retail Pharmacies
• Government Immunization Programs

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Sanofi
• Serum Institute of India Pvt. Ltd.
• Astellas Pharma India Private Limited
• Emergent BioSolutions Inc.
• GlaxoSmithKline plc

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References